 Abstract Submission Information and Guidelines
Information
- Use the online submission site to submit abstracts. For the best results, use Internet Explorer 6.0 or higher. Program enhancements may not be available if a lower version of Netscape or Internet Explorer is used.
- You can enter your abstract, save it, and return for edits or updates anytime prior to the deadline. Final submission must be made on or before May 4, 2009, at 12:00 pm (CT).
- After the submission deadline, all completed and submitted abstracts will be sent for review. Incomplete abstracts will be discarded.
- Electronic confirmation of your Abstract Author Agreement must accompany your submission. This agreement acknowledges that abstracts relating to human research have been subject to a investigational protocol review and approval by a formally constituted institutional review board for human studies.
- Receipt of abstracts will be acknowledged to the presenting author electronically; phone acknowledgements will not be made.
For technical assistance, contact techelp@chestnet.org.
For assistance with submission or presentation questions, contact Robb at rrabito@chestnet.org.
Guidelines
Abstracts must comply with the guidelines below. The ACCP reserves the right to reject abstracts for any reason, including failure to meet the submission requirements.
- Abstracts must be written and presented in English.
- The material submitted must be original and may not be presented or published elsewhere in abstract form prior to November 5, 2009.
- Submission of an abstract constitutes the author’s intent to present the abstract, as accepted, at CHEST 2009.
- The abstract title should define the topic and contain no abbreviations. Standard abbreviations may be used in the text of the abstract. On first use, the full term should be spelled out with the abbreviation in parentheses. Author names are not allowed in the title of the abstract and should be entered in the designated author information area.
- All submissions must be HIPAA-compliant. All individually identifiable health information is to remain private. Review HIPAA guidelines.
- All text must be submitted in the text box. A table may be used to highlight an important feature of the written content. Inclusion of a table has no impact on the decision to accept or reject an abstract, and tables will not be published.
- The total word count, excluding the optional table, may not exceed 325 words.
- Proprietary names of drugs are not allowed. Generic names must be used.
- Multiple abstracts focusing on different aspects of the same study will not be accepted. The Scientific Presentations and Awards Committee may request the information be combined into a single abstract.
- Abstracts submitted as case reports or literature reviews will not be accepted for abstract presentation. ACCP affiliate members are invited to submit case reports separately.
- All relevant presentation categories should be selected, and all contact information should be current and correct.
- Conflicts of interest must be disclosed for ALL AUTHORS. If you have nothing to disclose, indicate this by checking the appropriate box. Failure to disclose any grant support or funding will disqualify an abstract.
Abstracts will be evaluated individually on scientific merit and originality. Notification of acceptance or rejection will be made electronically to the presenting author after July 10, 2009. If you have not been notified by July 20, 2009, contact the ACCP.
The last day to edit or withdraw an accepted abstract is August 3, 2009. To withdraw an accepted abstract, e-mail Robb Rabito. Include your abstract control number.
|
